Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

Shigeki Kusamura ,Aviram Nissan,Tom Cecil,Jason M Foster,Peter Cashin,Victor J Verwaal,Michele De Simone,Pompiliu Piso,Sanjeev Dayal,Marc A Reymond,Paul H Sugarbaker,Beate Rau,Brian W Loggie,Yan Li,Yutaka Yonemura,I.H.J.T De Hingh,Marc Pocard,Malcom S Wilson,Yang Yu,Joel M Baumgartner,David L Morris,Faheez Mohamed,Kuno Lehmann,Lucas Sidéris ,Olivier Gléhen ,John Spiliotis ,Diane Goèré ,Brendan Moran ,Rossella Bertulli ,Almog Ben‐Yaacov ,Pedro Barrios-Sánchez ,Laurent Villeneuve ,Kurt Van Der Speeten ,Marcello Deraco ,Kim Govaerts ,Vahan Képénékian ,Robin J Lurvink

doi:10.1016/j.ejso.2020.02.011

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

Shigeki Kusamura , Aviram Nissan + Show 35 more

https://doi.org/10.1016/j.ejso.2020.02.011

Copy DOI

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))	Publication Date: Mar 12, 2020
Citations: 62

Affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori, Catharina Ziekenhuis, Radboud University Nijmegen, Hôpital Lyon Sud, Basingstoke and North Hampshire Hospital, Hospices Civils de Lyon, Ziekenhuis Oost-Limburg, Claude Bernard University Lyon 1

#Peritoneal Mesothelioma #Clinical Practice Guidelines For Diagnosis + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Peritoneal mesothelioma (PM) is a rare and aggressive primary peritoneal malignancy characterized by widespread multiple metastatic tumour nodules originating from the peritoneum. The conventional classification distinguishes diffuse malignant peritoneal mesothelioma (DMPM) and border-line forms: multicystic peritoneal mesothelioma (MCPM) and well-differentiated papillary peritoneal mesothelioma (WDPPM). Despite the novel achievements in the management of PM, there is difficulty in conducting randomized trials due to its rarity and aggressive biology in many cases.

Full Text